Sotera Health Company (SHC)
NASDAQ:SHC
Want to see SHC full AI Analyst Report?
SHC Stock Chart & Stats
$17.40
-$0.21(-1.56%)
At close: 4:00 PM EST
$17.40
-$0.21(-1.56%)
Day’s Range― - ―
52-Week Range$10.93 - $19.85
Previous CloseN/A
Volume149.43K
Average Volume (3M)3.56M
Market Cap
$4.88B
Enterprise Value$6.36B
Total Cash (Recent Filing)$315.94M
Total Debt (Recent Filing)$2.27B
Price to Earnings (P/E)41.6
Beta1.20
Next Earnings
Aug 06, 2026EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.41
Shares Outstanding285,167,000
10 Day Avg. Volume2,516,763
30 Day Avg. Volume3,556,085
Financial Highlights & Ratios
PEG Ratio0.95
Price to Book (P/B)8.27
Price to Sales (P/S)4.30
P/FCF Ratio33.58
Enterprise Value/Market Cap1.30
Enterprise Value/Revenue5.35
Enterprise Value/Gross Profit9.73
Enterprise Value/Ebitda13.02
Forecast
1Y Price Target
$21.33Price Target Upside22.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.97
Revenue Forecast (FY)$1.24B
Bulls Say, Bears Say
Bulls Say
Mission-critical, Recurring ServicesSotera’s core businesses (sterilization, lab testing, cobalt-60 supply) are required for product commercialization and regulatory compliance. That creates recurring, fee-based demand from regulated customers and supports durable revenue visibility tied to production volumes and audit-driven supplier selection.
Segment Diversification And Margin DriversStrong Nordion performance and Sterigenics pricing show portfolio balance between high‑margin isotope supply and contract sterilization. Diversified modalities (gamma, EO, e‑beam) and differentiated lab services help stabilize margins and reduce single‑point demand swings across medical and life‑sciences customers.
Improved Liquidity And Lower Borrowing CostsRepricing and extended term loans modestly lower interest expense and stretch maturities, easing refinancing risk. Combined with reported available liquidity above $900M, this provides durable financial flexibility to fund capex, EO upgrades and cobalt projects while pursuing leverage improvement toward target ranges.
Bears Say
High Leverage And Thin Equity BufferElevated debt (multi‑times equity) keeps the capital structure aggressive and raises sensitivity to interest rates, operational setbacks, or slower cash conversion. Even with improving returns, limited equity cushion reduces strategic optionality and raises refinancing and covenant risk over the medium term.
Volatile Cash Generation & Weak FCF ConversionInconsistent operating and free cash flow—including past negative years and recent meaningful FCF decline—limits capacity to delever, fund capex, or absorb legal payouts. Weak conversion of accounting earnings to cash makes leverage reduction and sustainable shareholder returns more uncertain over the medium term.
Regulatory And Litigation Exposure (EO & Legal Cases)EO regulatory outcomes and potential rule changes are structural for sterilization economics and capacity. Combined with ongoing litigation (bellwether dismissals but appeals possible), regulatory or legal setbacks could require further capital spending, disrupt volumes, or change customer mix over the medium term.
Sotera Health News
SHC FAQ
What was Sotera Health Company’s price range in the past 12 months?
Sotera Health Company lowest stock price was $10.93 and its highest was $19.85 in the past 12 months.
What is Sotera Health Company’s market cap?
Sotera Health Company’s market cap is $4.88B.
When is Sotera Health Company’s upcoming earnings report date?
Sotera Health Company’s upcoming earnings report date is Aug 06, 2026 which is in 41 days.
How were Sotera Health Company’s earnings last quarter?
Sotera Health Company released its earnings results on May 05, 2026. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.174 by $0.006.
Is Sotera Health Company overvalued?
According to Wall Street analysts Sotera Health Company’s price is currently Undervalued.
Does Sotera Health Company pay dividends?
Sotera Health Company does not currently pay dividends.
What is Sotera Health Company’s EPS estimate?
Sotera Health Company’s EPS estimate is 0.24.
How many shares outstanding does Sotera Health Company have?
Sotera Health Company has 285,167,000 shares outstanding.
What happened to Sotera Health Company’s price movement after its last earnings report?
Sotera Health Company reported an EPS of $0.18 in its last earnings report, beating expectations of $0.174. Following the earnings report the stock price went down -0.39%.
Which hedge fund is a major shareholder of Sotera Health Company?
Currently, no hedge funds are holding shares in SHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sotera Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$21.33 (22.61% Upside)
$21.33 (22.61% Upside)
Blogger Sentiment
Bullish
SHC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 521.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $482.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
48.48%
12-Months-Change
Fundamentals
Return on Equity
20.57%
Trailing 12-Months
Asset Growth
4.47%
Trailing 12-Months
Company Description
Sotera Health Company
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
SHC Company Deck
SHC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed predominantly positive operational and financial momentum: company delivered revenue and adjusted EBITDA growth, expanded margins, strong Nordion performance, improved adjusted EPS, meaningful legal dismissals, solid liquidity, and reaffirmed guidance. Key risks and near-term headwinds include Nelson Labs' revenue and margin pressure, some timing-driven results (Nordion harvest schedules and FX benefits), Sterigenics weather/downtime variability, elevated CapEx, and remaining leverage above target. Overall, the positive execution, legal outcomes, and reaffirmed outlook outweigh the identifiable challenges.View all SHC earnings summariesSHC Stock 12 Month Forecast
Average Price Target
$21.33
▲(22.61% Upside)
Technical Analysis
Ownership Overview
2.75% Insiders
15.20% Mutual Funds
56.85% Other Institutional Investors
6.35% Public Companies and
Individual Investors